Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma

Objective: Poorly differentiated thyroid carcinomas (PDTCs) are rare and aggressive head and neck malignancies with a poor prognosis. Systemic treatment for incurable PDTC consists of multi-kinase inhibitors (MKIs) based on extrapolation from the experience with radioiodine refractory differentiated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Omar Elghawy, Adam Barsouk, Jessica Xu, Simon Chen, Roger B Cohen, Lova Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Bioscientifica 2024-11-01
Colecção:	European Thyroid Journal
Assuntos:	poorly differentiated thyroid cancer thyroid cancer cabozantinib lenvatinib sorafenib
Acesso em linha:	https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0225.xml
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!